Commonwealth of Pennsylvania Public School Empls Retrmt SYS trimmed its position in shares of Stryker Co. (NYSE:SYK) by 24.3% during the third quarter, HoldingsChannel reports. The institutional investor owned 25,473 shares of the medical technology company’s stock after selling 8,171 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Stryker were worth $4,526,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Atlantic Trust LLC acquired a new stake in Stryker during the second quarter worth about $105,000. Centaurus Financial Inc. acquired a new stake in Stryker during the second quarter worth about $110,000. NuWave Investment Management LLC grew its stake in Stryker by 3,245.0% during the third quarter. NuWave Investment Management LLC now owns 669 shares of the medical technology company’s stock worth $119,000 after buying an additional 649 shares in the last quarter. Kaizen Advisory LLC grew its stake in Stryker by 142.6% during the second quarter. Kaizen Advisory LLC now owns 752 shares of the medical technology company’s stock worth $127,000 after buying an additional 442 shares in the last quarter. Finally, NumerixS Investment Technologies Inc acquired a new stake in Stryker during the second quarter worth about $135,000. Hedge funds and other institutional investors own 74.84% of the company’s stock.

A number of research firms have recently weighed in on SYK. Needham & Company LLC restated a “hold” rating on shares of Stryker in a research note on Tuesday, September 11th. Oppenheimer set a $170.00 price target on shares of Stryker and gave the company a “hold” rating in a research note on Friday, November 9th. Canaccord Genuity restated a “buy” rating and issued a $185.00 price target on shares of Stryker in a research note on Wednesday, July 25th. Royal Bank of Canada restated a “buy” rating and issued a $184.00 price target on shares of Stryker in a research note on Wednesday, July 25th. Finally, Zacks Investment Research downgraded shares of Stryker from a “buy” rating to a “hold” rating in a research note on Wednesday, August 8th. Seven analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $181.86.

In related news, CFO Glenn S. Boehnlein sold 750 shares of the firm’s stock in a transaction that occurred on Monday, October 1st. The shares were sold at an average price of $178.17, for a total value of $133,627.50. Following the completion of the transaction, the chief financial officer now owns 2,785 shares in the company, valued at approximately $496,203.45. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, VP M Kathryn Fink sold 415 shares of the firm’s stock in a transaction that occurred on Monday, November 5th. The shares were sold at an average price of $166.56, for a total transaction of $69,122.40. The disclosure for this sale can be found here. In the last quarter, insiders sold 39,031 shares of company stock valued at $6,520,313. 7.40% of the stock is owned by company insiders.

Shares of NYSE SYK opened at $172.16 on Monday. The company has a market capitalization of $64.42 billion, a P/E ratio of 26.53, a price-to-earnings-growth ratio of 2.37 and a beta of 0.64. Stryker Co. has a 1 year low of $146.80 and a 1 year high of $179.84. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.21.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Thursday, October 25th. The medical technology company reported $1.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.68 by $0.01. The business had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.26 billion. Stryker had a net margin of 9.31% and a return on equity of 28.00%. Analysts forecast that Stryker Co. will post 7.28 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 31st. Investors of record on Friday, September 28th were issued a $0.47 dividend. The ex-dividend date was Thursday, September 27th. This represents a $1.88 dividend on an annualized basis and a yield of 1.09%. Stryker’s dividend payout ratio (DPR) is presently 28.97%.

TRADEMARK VIOLATION WARNING: “Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $4.53 Million Holdings in Stryker Co. (SYK)” was first reported by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://www.dailypolitical.com/2018/11/19/commonwealth-of-pennsylvania-public-school-empls-retrmt-sys-has-4-53-million-holdings-in-stryker-co-syk.html.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Read More: What is cost of equity?

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.